XSpray Pharma AB (publ)
F:6XP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
XSpray Pharma AB (publ)
F:6XP
|
SE |
|
G
|
Gap Inc
F:GAP
|
US |
|
Biogaia AB
F:BGL
|
SE |
|
Mitsui & Co Ltd
F:MTS1
|
JP |
Shareholder Yield
Current shareholder yield for 
6XP is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
6XP Price
XSpray Pharma AB (publ)
| Average Annual Return | -21.02% |
| Standard Deviation of Annual Returns | 22.42% |
| Max Drawdown | -85% |
| Market Capitalization | 1.1B EUR |
| Shares Outstanding | 28 946 300 |
| Percentage of Shares Shorted |
N/A
|
